Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 294

1.

Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study.

Viola A, Monterubbianesi R, Scalisi G, Furfaro F, Rea M, Saibeni S, Aratari A, Bringiotti R, Casella G, Cantoro L, Frankovic I, Calella F, Pugliese D, Orlando S, Samperi L, Cappello M, Mocci G, Manetti N, Annese V, Privitera AC, Inserra G, Caprioli F, D'Incà R, Principi M, Papi C, Castiglione F, Danese S, Ardizzone S, Bossa F, Kohn A, Manguso F, Alibrandi A, Fiorino G, Armuzzi A, Fries W; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Eur J Gastroenterol Hepatol. 2019 Nov;31(11):1361-1369. doi: 10.1097/MEG.0000000000001546.

PMID:
31567640
2.

TDM of Anti-TNF Agents: The Importance of Being Active!

Annese V.

Inflamm Bowel Dis. 2019 Jun 27. pii: izz132. doi: 10.1093/ibd/izz132. [Epub ahead of print] No abstract available.

PMID:
31247072
3.

Multimodal Integrated Sensor Platform for Rapid Biomarker Detection.

Al-Rawhani MA, Hu C, Giagkoulovits C, Annese V, Chong Cheah B, Beeley JM, Velugotla S, Accarino C, Grant J, Mitra S, Barrett M, Cochran S, Cumming D.

IEEE Trans Biomed Eng. 2019 Jun 19. doi: 10.1109/TBME.2019.2919192. [Epub ahead of print]

PMID:
31226063
4.

A Review of Extraintestinal Manifestations and Complications of Inflammatory Bowel Disease.

Annese V.

Saudi J Med Med Sci. 2019 May-Aug;7(2):66-73. doi: 10.4103/sjmms.sjmms_81_18. Epub 2019 Apr 12. Review.

5.

Progenitor Cell Heterogeneity in the Adult Carotid Body Germinal Niche.

Sobrino V, Annese V, Pardal R.

Adv Exp Med Biol. 2019;1123:19-38. doi: 10.1007/978-3-030-11096-3_3. Review.

PMID:
31016593
6.

Corrigendum: Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial.

Domènech E, Panés J, Hinojosa J, Annese V, Magro F, Sturniolo GC, Bossa F, Fernández F, González-Conde B, García-Sánchez V, Dignass A, Herrera JM, Cabriada JL, Guardiola J, Vecchi M, Portela F, Ginard D; ATTICA Study Group by the Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa.

J Crohns Colitis. 2019 May 27;13(6):814. doi: 10.1093/ecco-jcc/jjy211. No abstract available.

PMID:
30951596
7.

Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Fiorino G, Caprioli F, Daperno M, Mocciaro F, Principi M, Viscido A, Fantini MC, Orlando A, Papi C, Annese V, Danese S, Vecchi M, Rizzello F, Armuzzi A; National patients’ association representatives; IG-IBD members.

Dig Liver Dis. 2019 May;51(5):632-639. doi: 10.1016/j.dld.2019.02.004. Epub 2019 Feb 19.

PMID:
30872085
8.

Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease.

Walker GJ, Harrison JW, Heap GA, Voskuil MD, Andersen V, Anderson CA, Ananthakrishnan AN, Barrett JC, Beaugerie L, Bewshea CM, Cole AT, Cummings FR, Daly MJ, Ellul P, Fedorak RN, Festen EAM, Florin TH, Gaya DR, Halfvarson J, Hart AL, Heerasing NM, Hendy P, Irving PM, Jones SE, Koskela J, Lindsay JO, Mansfield JC, McGovern D, Parkes M, Pollok RCG, Ramakrishnan S, Rampton DS, Rivas MA, Russell RK, Schultz M, Sebastian S, Seksik P, Singh A, So K, Sokol H, Subramaniam K, Todd A, Annese V, Weersma RK, Xavier R, Ward R, Weedon MN, Goodhand JR, Kennedy NA, Ahmad T; IBD Pharmacogenetics Study Group.

JAMA. 2019 Feb 26;321(8):773-785. doi: 10.1001/jama.2019.0709. Erratum in: JAMA. 2019 Apr 23;321(16):1636.

9.

Biosimilars in IBD: Similarity Breeds Contented Patients.

Annese V.

Dig Dis Sci. 2019 Jun;64(6):1399-1400. doi: 10.1007/s10620-019-05499-5. No abstract available.

PMID:
30725297
10.

The carotid body: a physiologically relevant germinal niche in the adult peripheral nervous system.

Sobrino V, Annese V, Navarro-Guerrero E, Platero-Luengo A, Pardal R.

Cell Mol Life Sci. 2019 Mar;76(6):1027-1039. doi: 10.1007/s00018-018-2975-9. Epub 2018 Nov 29. Review.

PMID:
30498994
11.

Computed tomography or contrast-enhanced ultrasonography for follow-up of liver metastases after Cyberknife therapy?: A prospective pilot study.

Marsico M, Gabbani T, Lunardi S, Lei B, Lucarini M, Cuffari B, Curatolo A, Biagini MR, Annese V.

J Ultrasound Med. 2019 Mar;38(3):649-655. doi: 10.1002/jum.14734. Epub 2018 Sep 4.

PMID:
30182490
12.

The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy.

Armuzzi A, Fiorino G, Variola A, Manetti N, Fries W, Orlando A, Maconi G, Bossa F, Cappello M, Biancone L, Cantoro L, Costa F, D'Incà R, Lionetti P, Principi M, Castiglione F, Annunziata ML, Di Sabatino A, Di Girolamo M, Terpin MM, Cortelezzi CC, Saibeni S, Amato A, Ardizzone S, Guidi L, Danese S, Massella A, Ventra A, Rizzuto G, Massari A, Perri F, Annese V; PROSIT Investigators.

Inflamm Bowel Dis. 2019 Feb 21;25(3):568-579. doi: 10.1093/ibd/izy264.

PMID:
30137352
13.

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects.

Sturm A, Maaser C, Calabrese E, Annese V, Fiorino G, Kucharzik T, Vavricka SR, Verstockt B, van Rheenen P, Tolan D, Taylor SA, Rimola J, Rieder F, Limdi JK, Laghi A, Krustiņš E, Kotze PG, Kopylov U, Katsanos K, Halligan S, Gordon H, González Lama Y, Ellul P, Eliakim R, Castiglione F, Burisch J, Borralho Nunes P, Bettenworth D, Baumgart DC, Stoker J; European Crohn’s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR].

J Crohns Colitis. 2019 Mar 26;13(3):273-284. doi: 10.1093/ecco-jcc/jjy114. No abstract available.

PMID:
30137278
14.

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications.

Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, Calabrese E, Baumgart DC, Bettenworth D, Borralho Nunes P, Burisch J, Castiglione F, Eliakim R, Ellul P, González-Lama Y, Gordon H, Halligan S, Katsanos K, Kopylov U, Kotze PG, Krustinš E, Laghi A, Limdi JK, Rieder F, Rimola J, Taylor SA, Tolan D, van Rheenen P, Verstockt B, Stoker J; European Crohn’s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR].

J Crohns Colitis. 2019 Feb 1;13(2):144-164. doi: 10.1093/ecco-jcc/jjy113. No abstract available.

PMID:
30137275
15.

Promoter methylation of the MGAT3 and BACH2 genes correlates with the composition of the immunoglobulin G glycome in inflammatory bowel disease.

Klasić M, Markulin D, Vojta A, Samaržija I, Biruš I, Dobrinić P, Ventham NT, Trbojević-Akmačić I, Šimurina M, Štambuk J, Razdorov G, Kennedy NA, Satsangi J, Dias AM, Pinho S, Annese V, Latiano A, D'Inca R; IBD consortium, Lauc G, Zoldoš V.

Clin Epigenetics. 2018 Jun 4;10:75. doi: 10.1186/s13148-018-0507-y. eCollection 2018.

16.

Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases.

Clerc F, Novokmet M, Dotz V, Reiding KR, de Haan N, Kammeijer GSM, Dalebout H, Bladergroen MR, Vukovic F, Rapp E; IBD-BIOM Consortium, Targan SR, Barron G, Manetti N, Latiano A, McGovern DPB, Annese V, Lauc G, Wuhrer M.

Gastroenterology. 2018 Sep;155(3):829-843. doi: 10.1053/j.gastro.2018.05.030. Epub 2018 May 21.

PMID:
29792883
17.

Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial.

Domènech E, Panés J, Hinojosa J, Annese V, Magro F, Sturniolo GC, Bossa F, Fernández F, González-Conde B, García-Sánchez V, Dignass A, Herrera JM, Cabriada JL, Guardiola J, Vecchi M, Portela F, Ginard D; ATTICA Study Group by the Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa [listed at the end of the article] .

J Crohns Colitis. 2018 May 25;12(6):687-694. doi: 10.1093/ecco-jcc/jjy023. Erratum in: J Crohns Colitis. 2019 May 27;13(6):814.

PMID:
29490024
18.

Fast neurogenesis from carotid body quiescent neuroblasts accelerates adaptation to hypoxia.

Sobrino V, González-Rodríguez P, Annese V, López-Barneo J, Pardal R.

EMBO Rep. 2018 Mar;19(3). pii: e44598. doi: 10.15252/embr.201744598. Epub 2018 Jan 15.

19.

Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases.

Šimurina M, de Haan N, Vučković F, Kennedy NA, Štambuk J, Falck D, Trbojević-Akmačić I, Clerc F, Razdorov G, Khon A, Latiano A, D'Incà R, Danese S, Targan S, Landers C, Dubinsky M; Inflammatory Bowel Disease Biomarkers Consortium, McGovern DPB, Annese V, Wuhrer M, Lauc G.

Gastroenterology. 2018 Apr;154(5):1320-1333.e10. doi: 10.1053/j.gastro.2018.01.002. Epub 2018 Jan 6.

20.

Authors' answers on comment of Abellona et al. on Metabolomic analysis for noninvasive diagnosis of hepatic fibrosis degree in patients with chronic hepatitis C.

Marsico M, Gabbani T, Cuffari B, Biagini MR, Annese V.

Dig Liver Dis. 2018 Feb;50(2):210-211. doi: 10.1016/j.dld.2017.10.019. Epub 2017 Nov 7. No abstract available.

PMID:
29153488
21.

CT-P13: design, development, and place in therapy.

Gabbani T, Deiana S, Annese V.

Drug Des Devel Ther. 2017 Jun 6;11:1653-1661. doi: 10.2147/DDDT.S109852. eCollection 2017. Review.

22.

Metabolomic analysis with 1H-NMR for non-invasive diagnosis of hepatic fibrosis degree in patients with chronic hepatitis C.

Gabbani T, Marsico M, Bernini P, Lorefice E, Grappone C, Biagini MR, Milani S, Annese V.

Dig Liver Dis. 2017 Dec;49(12):1338-1344. doi: 10.1016/j.dld.2017.05.018. Epub 2017 Jun 13.

PMID:
28625405
23.

Percutaneous ultrasound-guided fiducial marker placement for liver cancer robotic stereotactic radio-surgery treatment: A comparative analysis of three types of markers and needles.

Marsico M, Gabbani T, Lunardi S, Galli A, Biagini MR, Annese V.

Arab J Gastroenterol. 2017 Jun;18(2):83-86. doi: 10.1016/j.ajg.2017.05.007. Epub 2017 Jun 1.

PMID:
28579341
24.

Physiological Plasticity of Neural-Crest-Derived Stem Cells in the Adult Mammalian Carotid Body.

Annese V, Navarro-Guerrero E, Rodríguez-Prieto I, Pardal R.

Cell Rep. 2017 Apr 18;19(3):471-478. doi: 10.1016/j.celrep.2017.03.065.

25.

Crohn's Colitis: Development of a multiplex gene expression assay comparing mRNA levels of susceptibility genes.

Russo E, Lombardelli L, Giudici F, Cavalli T, Ficari F, Fazi M, Scaringi S, Biancone L, Logiodice F, Nesi M, Latiano A, Annese V, Torcia MG, Bechi P, Tonelli F, Piccinni MP, Malentacchi C.

Clin Res Hepatol Gastroenterol. 2017 Sep;41(4):435-444. doi: 10.1016/j.clinre.2017.02.004. Epub 2017 Mar 30.

PMID:
28365139
26.

Allele-specific transcriptional activity of the variable number of tandem repeats of the inducible nitric oxide synthase gene is associated with idiopathic achalasia.

Sarnelli G, Grosso M, Palumbo I, Pesce M, D'Alessandro A, Zaninotto G, Annese V, Petruzzelli R, Izzo P, Sepulveres R, Bruzzese D, Esposito G, Cuomo R.

United European Gastroenterol J. 2017 Mar;5(2):200-207. doi: 10.1177/2050640616648870. Epub 2016 Jul 8.

27.

Genetic risk variants as therapeutic targets for Crohn's disease.

Gabbani T, Deiana S, Marocchi M, Annese V.

Expert Opin Ther Targets. 2017 Apr;21(4):381-390. doi: 10.1080/14728222.2017.1296431. Epub 2017 Mar 1. Review.

PMID:
28281904
28.

Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease.

Gionchetti P, Rizzello F, Annese V, Armuzzi A, Biancone L, Castiglione F, Comberlato M, Cottone M, Danese S, Daperno M, D'Incà R, Fries W, Kohn A, Orlando A, Papi C, Vecchi M, Ardizzone S; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Dig Liver Dis. 2017 Jun;49(6):604-617. doi: 10.1016/j.dld.2017.01.161. Epub 2017 Jan 25.

PMID:
28254463
29.

Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Biancone L, Annese V, Ardizzone S, Armuzzi A, Calabrese E, Caprioli F, Castiglione F, Comberlato M, Cottone M, Danese S, Daperno M, D'Incà R, Frieri G, Fries W, Gionchetti P, Kohn A, Latella G, Milla M, Orlando A, Papi C, Petruzziello C, Riegler G, Rizzello F, Saibeni S, Scribano ML, Vecchi M, Vernia P, Meucci G; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Dig Liver Dis. 2017 Apr;49(4):338-358. doi: 10.1016/j.dld.2017.01.141. Epub 2017 Jan 17.

PMID:
28161290
30.

Biosimilars in inflammatory bowel disease: A review of post-marketing experience.

Deiana S, Gabbani T, Annese V.

World J Gastroenterol. 2017 Jan 14;23(2):197-203. doi: 10.3748/wjg.v23.i2.197. Review.

31.

The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.

Fiorino G, Manetti N, Armuzzi A, Orlando A, Variola A, Bonovas S, Bossa F, Maconi G, DʼIncà R, Lionetti P, Cantoro L, Fries W, Annunziata ML, Costa F, Terpin MM, Biancone L, Cortelezzi CC, Amato A, Ardizzone S, Danese S, Guidi L, Rizzuto G, Massella A, Andriulli A, Massari A, Lorenzon G, Ghione S, Kohn A, Ventra A, Annese V; PROSIT-BIO Cohort.

Inflamm Bowel Dis. 2017 Feb;23(2):233-243. doi: 10.1097/MIB.0000000000000995.

PMID:
28092307
32.

Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel Disease.

Costa Pereira C, Durães C, Coelho R, Grácio D, Silva M, Peixoto A, Lago P, Pereira M, Catarino T, Pinho S, Teixeira JP, Macedo G, Annese V, Magro F.

PLoS One. 2017 Jan 4;12(1):e0169102. doi: 10.1371/journal.pone.0169102. eCollection 2017.

33.

European Crohn's and Colitis Organisation Topical Review on Environmental Factors in IBD.

Maaser C, Langholz E, Gordon H, Burisch J, Ellul P, Ramirez VH, Karakan T, Katsanos KH, Krustins E, Levine A, Mantzaris GJ, O'Morain C, Strid H, Yuksel ES, Annese V.

J Crohns Colitis. 2017 Aug 1;11(8):905-920. doi: 10.1093/ecco-jcc/jjw223. Review.

PMID:
28039310
34.

Percutaneous ultrasound-guided bowel biopsy of a pseudokidney mass.

Marsico M, Gabbani T, Margherita M, Lunardi S, Biagini MR, Annese V.

Turk J Gastroenterol. 2017 Jan;28(1):60-62. doi: 10.5152/tjg.2016.0584. Epub 2016 Dec 23. No abstract available.

35.

Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions.

Vultaggio A, Petroni G, Pratesi S, Nencini F, Cammelli D, Milla M, Prignano F, Annese V, Romagnani S, Maggi E, Matucci A; ABIRISK Consortium.

Clin Exp Immunol. 2016 Dec;186(3):364-372. doi: 10.1111/cei.12858. Epub 2016 Oct 26.

36.

The natural history of Crohn's disease in children: a review of population-based studies.

Duricova D, Fumery M, Annese V, Lakatos PL, Peyrin-Biroulet L, Gower-Rousseau C.

Eur J Gastroenterol Hepatol. 2017 Feb;29(2):125-134. doi: 10.1097/MEG.0000000000000761. Review.

PMID:
27748673
37.

Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD "AGED study".

Fries W, Viola A, Manetti N, Frankovic I, Pugliese D, Monterubbianesi R, Scalisi G, Aratari A, Cantoro L, Cappello M, Samperi L, Saibeni S, Casella G, Mocci G, Rea M, Furfaro F, Contaldo A, Magarotto A, Calella F, Manguso F, Inserra G, Privitera AC, Principi M, Castiglione F, Caprioli F, Ardizzone S, Danese S, Papi C, Bossa F, Kohn A, Armuzzi A, D'Incà R, Annese V, Alibrandi A, Bonovas S, Fiorino G; Italian Group for the study of Inflammatory Bowel Disease (IG-IBD).

Dig Liver Dis. 2017 Jan;49(1):17-23. doi: 10.1016/j.dld.2016.09.006. Epub 2016 Sep 21.

PMID:
27717794
38.

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management.

Gomollón F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, Peyrin-Biroulet L, Cullen GJ, Daperno M, Kucharzik T, Rieder F, Almer S, Armuzzi A, Harbord M, Langhorst J, Sans M, Chowers Y, Fiorino G, Juillerat P, Mantzaris GJ, Rizzello F, Vavricka S, Gionchetti P; ECCO.

J Crohns Colitis. 2017 Jan;11(1):3-25. doi: 10.1093/ecco-jcc/jjw168. Epub 2016 Sep 22.

PMID:
27660341
39.

Erratum: A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis.

Rivas MA, Graham D, Sulem P, Stevens C, Desch AN, Goyette P, Gudbjartsson D, Jonsdottir I, Thorsteinsdottir U, Degenhardt F, Mucha S, Kurki MI, Li D, D'Amato M, Annese V, Vermeire S, Weersma RK, Halfvarson J, Paavola-Sakki P, Lappalainen M, Lek M, Cummings B, Tukiainen T, Haritunians T, Halme L, Koskinen LL, Ananthakrishnan AN, Luo Y, Heap GA, Visschedijk MC; UK IBD Genetics Consortium; NIDDK IBD Genetics Consortium, MacArthur DG, Neale BM, Ahmad T, Anderson CA, Brant SR, Duerr RH, Silverberg MS, Cho JH, Palotie A, Saavalainen P, Kontula K, Färkkilä M, McGovern DP, Franke A, Stefansson K, Rioux JD, Xavier RJ, Daly MJ.

Nat Commun. 2016 Sep 13;7:12869. doi: 10.1038/ncomms12869. No abstract available.

40.

Outcome of acute severe ulcerative colitis in patients previously exposed to immunosuppressive therapy.

Deiana S, Bagnoli S, Manetti N, Caini S, Giannotta M, Scaringi S, Annese V.

Dig Liver Dis. 2016 Dec;48(12):1432-1437. doi: 10.1016/j.dld.2016.07.021. Epub 2016 Aug 1.

PMID:
27553087
41.

Prospective Evaluation of Liver Stiffness Using Transient Elastography in Alcoholic Patients Following Abstinence.

Gianni E, Forte P, Galli V, Razzolini G, Bardazzi G, Annese V.

Alcohol Alcohol. 2017 Jan;52(1):42-47. doi: 10.1093/alcalc/agw053. Epub 2016 Aug 19.

PMID:
27542989
42.

A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis.

Rivas MA, Graham D, Sulem P, Stevens C, Desch AN, Goyette P, Gudbjartsson D, Jonsdottir I, Thorsteinsdottir U, Degenhardt F, Mucha S, Kurki MI, Li D, D'Amato M, Annese V, Vermeire S, Weersma RK, Halfvarson J, Paavola-Sakki P, Lappalainen M, Lek M, Cummings B, Tukiainen T, Haritunians T, Halme L, Koskinen LL, Ananthakrishnan AN, Luo Y, Heap GA, Visschedijk MC; UK IBD Genetics Consortium; NIDDK IBD Genetics Consortium, MacArthur DG, Neale BM, Ahmad T, Anderson CA, Brant SR, Duerr RH, Silverberg MS, Cho JH, Palotie A, Saavalainen P, Kontula K, Färkkilä M, McGovern DP, Franke A, Stefansson K, Rioux JD, Xavier RJ, Daly MJ, Barrett J, de Lane K, Edwards C, Hart A, Hawkey C, Jostins L, Kennedy N, Lamb C, Lee J, Lees C, Mansfield J, Mathew C, Mowatt C, Newman B, Nimmo E, Parkes M, Pollard M, Prescott N, Randall J, Rice D, Satsangi J, Simmons A, Tremelling M, Uhlig H, Wilson D, Abraham C, Achkar JP, Bitton A, Boucher G, Croitoru K, Fleshner P, Glas J, Kugathasan S, Limbergen JV, Milgrom R, Proctor D, Regueiro M, Schumm PL, Sharma Y, Stempak JM, Targan SR, Wang MH.

Nat Commun. 2016 Aug 9;7:12342. doi: 10.1038/ncomms12342. Erratum in: Nat Commun. 2016 Sep 13;7:12869.

43.

Safety profile of methotrexate in inflammatory bowel disease.

Gabbani T, Deiana S, Lunardi S, Manetti N, Annese V.

Expert Opin Drug Saf. 2016 Oct;15(10):1427-37. doi: 10.1080/14740338.2016.1218468. Epub 2016 Aug 8. Review.

PMID:
27462711
44.

The genetic burden of inflammatory bowel diseases: implications for the clinic?

Gabbani T, Deiana S, Annese AL, Lunardi S, Annese V.

Expert Rev Gastroenterol Hepatol. 2016 Oct;10(10):1109-1117. doi: 10.1080/17474124.2016.1196131. Epub 2016 Jun 9.

PMID:
27258545
45.

Vitamin D regulates the tight-junction protein expression in active ulcerative colitis.

Stio M, Retico L, Annese V, Bonanomi AG.

Scand J Gastroenterol. 2016 Oct;51(10):1193-9. doi: 10.1080/00365521.2016.1185463. Epub 2016 May 20.

PMID:
27207502
46.

Pre- and post-procedural quality indicators for colonoscopy: A nationwide survey.

Paggi S, Amato A, Anderloni A, Annese V, Barresi L, Buda A, Cesaro P, Di Giulio E, Gullotti G, Fabbri C, Fiori G, Fuccio L, Manno M, Musso A, Rondonotti E, Trovato C, Hassan C, Repici A, Radaelli F; Bowell Group.

Dig Liver Dis. 2016 Jul;48(7):759-64. doi: 10.1016/j.dld.2016.03.017. Epub 2016 Mar 29.

PMID:
27116930
47.

Disease Course and Colectomy Rate of Ulcerative Colitis: A Follow-up Cohort Study of a Referral Center in Tuscany.

Manetti N, Bagnoli S, Rogai F, Bonanomi AG, Vannozzi G, Giannotta M, Annese V.

Inflamm Bowel Dis. 2016 Aug;22(8):1945-53. doi: 10.1097/MIB.0000000000000787.

PMID:
27104823
48.

The HLA-DQβ1 insertion is a strong achalasia risk factor and displays a geospatial north-south gradient among Europeans.

Becker J, Haas SL, Mokrowiecka A, Wasielica-Berger J, Ateeb Z, Bister J, Elbe P, Kowalski M, Gawron-Kiszka M, Majewski M, Mulak A, Janiak M, Wouters MM, Schwämmle T, Hess T, Veits L, Niebisch S, Santiago JL, de León AR, de la Serna JP, Urcelay E, Annese V, Latiano A, Fumagalli U, Rosati R, Laghi L, Cuomo R, Lenze F, Sarnelli G, Müller M, von Rahden BH, Wijmenga C, Lang H, Czene K, Hall P, de Bakker PI, Vieth M, Nöthen MM, Schulz HG, Adrych K, Gąsiorowska A, Paradowski L, Wallner G, Boeckxstaens GE, Gockel I, Hartleb M, Kostic S, Dziurkowska-Marek A, Lindblad M, Nilsson M, Knapp M, Thorell A, Marek T, Dąbrowski A, Małecka-Panas E, Schumacher J.

Eur J Hum Genet. 2016 Aug;24(8):1228-31. doi: 10.1038/ejhg.2015.262. Epub 2016 Jan 6.

49.

Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.

Heap GA, So K, Weedon M, Edney N, Bewshea C, Singh A, Annese V, Beckly J, Buurman D, Chaudhary R, Cole AT, Cooper SC, Creed T, Cummings F, de Boer NK, D'Inca R, D'Souza R, Daneshmend TK, Delaney M, Dhar A, Direkze N, Dunckley P, Gaya DR, Gearry R, Gore S, Halfvarson J, Hart A, Hawkey CJ, Hoentjen F, Iqbal T, Irving P, Lal S, Lawrance I, Lees CW, Lockett M, Mann S, Mansfield J, Mowat C, Mulgrew CJ, Muller F, Murray C, Oram R, Orchard T, Parkes M, Phillips R, Pollok R, Radford-Smith G, Sebastian S, Sen S, Shirazi T, Silverberg M, Solomon L, Sturniolo GC, Thomas M, Tremelling M, Tsianos EV, Watts D, Weaver S, Weersma RK, Wesley E, Holden A, Ahmad T.

J Crohns Colitis. 2016 Feb;10(2):149-58. doi: 10.1093/ecco-jcc/jjv219. Epub 2015 Nov 29. Erratum in: J Crohns Colitis. 2017 Dec 4;11(12):1509.

PMID:
26619893
50.

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease.

Harbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM, Burisch J, De Vos M, De Vries AM, Dick AD, Juillerat P, Karlsen TH, Koutroubakis I, Lakatos PL, Orchard T, Papay P, Raine T, Reinshagen M, Thaci D, Tilg H, Carbonnel F; European Crohn’s and Colitis Organisation.

J Crohns Colitis. 2016 Mar;10(3):239-54. doi: 10.1093/ecco-jcc/jjv213. Epub 2015 Nov 27. No abstract available.

Supplemental Content

Loading ...
Support Center